Acurox™

  Commercial Agreements
 
  
 
Home
Aversion® Technology
Acurox™ Tablets
Patents and Trademarks
Market Opportunities
Commercial Agreements
Culver Facility
Management Team
Board of Directors
Press Releases
SEC Filings & Stock Price
Employment Opportunities
Company Contacts
Forward Looking Statement
Company Risk Factors
Ethics/Audit Charter
Privacy Policy & Disclaimer
 
Management Team

Andrew D. Reddick
 
President, Chief Executive Officer, Director

Robert B. Jones
 
Senior Vice President and Chief Operating Officer

Ron J. Spivey, Ph.D.
 
Senior Vice President and Chief Scientific Officer

Peter A. Clemens, CPA
 
Senior Vice President Investor and Media Relations, Chief Financial Officer and Secretary

James F. Emigh, R.Ph.
 
Vice President of Marketing and Administration

Robert A. Seiser, CPA
 
Vice President, Treasurer and Corporate Controller

John G. Gilkay, P.E.
 
Director of EHS & Engineering

Ronald L. Leech
 
Senior Director Quality & Analytical Chemistry

Gregory A. Spinner
 
Director of Logistics and Special Projects

 
   
Home   Sitemap
Copyright © 1998-2008 Acura Pharmaceuticals.  All rights reserved.